Catherine Beech
Fondateur chez Exonate Ltd.
Profil
Catherine Susan Minshull-Beech is the founder and currently holds the position of Chief Executive Officer & Director at Exonate Ltd., a company founded in 2013.
She is also currently working as a Senior Director at Sage Healthcare Ltd., a Non-Executive Director at Locate Bio Ltd., a Board Member at PBL-Ventures, a Member at CFA Society of the UK, and an Advisor at o2h Ltd.
In her former positions, Dr. Minshull-Beech has worked as the Chief Executive Officer at Aitua Ltd., Chairman at PhoreMost Ltd., Senior Director-Medical Affairs at DuPont Pharmaceuticals Co., Non-Executive Director at Chameleon BioSurfaces Ltd., Director-Medical Affairs at Farmitalia Carlo Erba SRL, and Director at Oval Medical Technologies Ltd.Dr. Minshull-Beech completed her undergraduate and graduate degrees at the University of Birmingham.
Postes actifs de Catherine Beech
| Sociétés | Poste | Début |
|---|---|---|
Sage Healthcare Ltd.
 Sage Healthcare Ltd. Miscellaneous Commercial ServicesCommercial Services Sage Healthcare Ltd. provides management consulting services to the healthcare industry. The firm's services include strategic analysis and development; mergers and acquisitions; business development, support, and planning; corporate partnering; licensing and venturing; technology and compound brokerage; valuations and value-enhancement planning; forecasting; risk assessment and due diligence; and commercial and technical assessment. The company was founded in 1995 and is headquartered in Great Shelford, GB. | Directeur/Membre du Conseil | - |
CFA Society of the UK
 CFA Society of the UK Miscellaneous Commercial ServicesCommercial Services CFA Society of the UK is an association of investment professionals based in the UK. The British company was founded in an unspecified year. | Corporate Officer/Principal | - |
Exonate Ltd.
 Exonate Ltd. Medical/Nursing ServicesHealth Services Exonate engages in the discovery and development of small molecule drugs that modulate alternative mRNA splicing to address diseases of high unmet medical need. It develops SPHINXes, a pipeline of novel small molecule inhibitors. The company was founded by David Owen Bates, Lucy Donaldson, Steeven J. harper and Catherine Beech in 2013 and is headquartered in Nottingham, the United Kingdom. | Fondateur | 05/12/2013 |
Locate Bio Ltd.
 Locate Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Locate Bio Ltd. operates as a regenerative medicine development company. The firm focuses on clinical problems in which regeneration of human tissue will displace biomaterial or drug therapies. Its products are orthopaedic matrices with unique properties for hard to heal clinical applications. The company was founded by Robin Quirk and is headquartered in Nottingham, the United Kingdom. | Directeur/Membre du Conseil | - |
o2h Ltd
 o2h Ltd Investment ManagersFinance O2h Ltd (O2h) is a venture capital firm. The firm is founded by Sunil and Prashant Shah. It is headquartered in United Kingdom. | Consultant / Advisor | - |
PBL-Ventures
 PBL-Ventures Investment ManagersFinance PBL-Ventures is the business start-up and mentoring arm of Plant Bioscience Ltd founded in 1994. The firm is headquartered in the UK. | Directeur/Membre du Conseil | - |
Anciens postes connus de Catherine Beech
| Sociétés | Poste | Fin |
|---|---|---|
PhoreMost Ltd.
 PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom. | Président | 02/03/2022 |
Chameleon BioSurfaces Ltd.
 Chameleon BioSurfaces Ltd. Miscellaneous Commercial ServicesCommercial Services Chameleon BioSurfaces is a provider of sophisticated surface design technology to medical device companies. Chameleon works closely with its customers to design and produce unique solutions to specific device challenges and opportunities. The company specialized in using electro-deposition to apply polymers to the surfaces of medical implants and devices to improve the functionality, performance and reliability of such systems. Its polymers can impart such features as lubricity, wettability, bio-compatibility and drug-elution. The company can design surfaces so that drugs have a desired elution profile over time or are retained and presented at the device surface. Also, it had unique patented technology to enable, for certain device configurations, on & off switching and extremely precise control of the amount, timing and location of drug release. Chameleon's patented polymer deposition methods offer many manufacturing and process advantages. Polymers can be deposited in discrete patterns and gradients as well as uniformly over a device surface. Multiple polymer layers, each with a different functionality, allow highly sophisticated design features. Its electro-deposition methods ensure complete coverage even of complex and intricate surfaces, and also afford exquisite control of coating thickness, from sub-micron level upwards. | Directeur/Membre du Conseil | 10/12/2012 |
| Farmitalia Carlo Erba SRL | Directeur Technique/Scientifique/R&D | - |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Formation de Catherine Beech
| University of Birmingham | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Chameleon BioSurfaces Ltd.
Chameleon BioSurfaces Ltd. Miscellaneous Commercial ServicesCommercial Services Chameleon BioSurfaces is a provider of sophisticated surface design technology to medical device companies. Chameleon works closely with its customers to design and produce unique solutions to specific device challenges and opportunities. The company specialized in using electro-deposition to apply polymers to the surfaces of medical implants and devices to improve the functionality, performance and reliability of such systems. Its polymers can impart such features as lubricity, wettability, bio-compatibility and drug-elution. The company can design surfaces so that drugs have a desired elution profile over time or are retained and presented at the device surface. Also, it had unique patented technology to enable, for certain device configurations, on & off switching and extremely precise control of the amount, timing and location of drug release. Chameleon's patented polymer deposition methods offer many manufacturing and process advantages. Polymers can be deposited in discrete patterns and gradients as well as uniformly over a device surface. Multiple polymer layers, each with a different functionality, allow highly sophisticated design features. Its electro-deposition methods ensure complete coverage even of complex and intricate surfaces, and also afford exquisite control of coating thickness, from sub-micron level upwards. | Commercial Services |
Oval Medical Technologies Ltd.
 Oval Medical Technologies Ltd. Medical SpecialtiesHealth Technology Oval Medical Technologies Ltd. manufactures drug delivery devices focusing on vials, prefilled syringes, and autoinjectors. It provides an environment for the storage of all drugs including fragile biologics. The company was founded by Matthew Young in 2009 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Health Technology |
Aitua Ltd.
 Aitua Ltd. Investment ManagersFinance Aitua Ltd. engages in the commercialization of intellectual properties of companies in the field of life sciences. It provides support to new bio-ventures by investing in the initial stage. The company was founded in June 2006 and is headquartered in Cambridge, the United Kingdom. | Finance |
Sage Healthcare Ltd.
Sage Healthcare Ltd. Miscellaneous Commercial ServicesCommercial Services Sage Healthcare Ltd. provides management consulting services to the healthcare industry. The firm's services include strategic analysis and development; mergers and acquisitions; business development, support, and planning; corporate partnering; licensing and venturing; technology and compound brokerage; valuations and value-enhancement planning; forecasting; risk assessment and due diligence; and commercial and technical assessment. The company was founded in 1995 and is headquartered in Great Shelford, GB. | Commercial Services |
CFA Society of the UK
CFA Society of the UK Miscellaneous Commercial ServicesCommercial Services CFA Society of the UK is an association of investment professionals based in the UK. The British company was founded in an unspecified year. | Commercial Services |
| Farmitalia Carlo Erba SRL | Health Technology |
Exonate Ltd.
Exonate Ltd. Medical/Nursing ServicesHealth Services Exonate engages in the discovery and development of small molecule drugs that modulate alternative mRNA splicing to address diseases of high unmet medical need. It develops SPHINXes, a pipeline of novel small molecule inhibitors. The company was founded by David Owen Bates, Lucy Donaldson, Steeven J. harper and Catherine Beech in 2013 and is headquartered in Nottingham, the United Kingdom. | Health Services |
Locate Bio Ltd.
Locate Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Locate Bio Ltd. operates as a regenerative medicine development company. The firm focuses on clinical problems in which regeneration of human tissue will displace biomaterial or drug therapies. Its products are orthopaedic matrices with unique properties for hard to heal clinical applications. The company was founded by Robin Quirk and is headquartered in Nottingham, the United Kingdom. | Commercial Services |
PhoreMost Ltd.
PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
o2h Ltd
o2h Ltd Investment ManagersFinance O2h Ltd (O2h) is a venture capital firm. The firm is founded by Sunil and Prashant Shah. It is headquartered in United Kingdom. | Finance |
PBL-Ventures
PBL-Ventures Investment ManagersFinance PBL-Ventures is the business start-up and mentoring arm of Plant Bioscience Ltd founded in 1994. The firm is headquartered in the UK. | Finance |
